N-Sorb leverages company’s proven 3-Phase Activ-Polymer™ platform technology to address recent concerns related to N-nitrosamine impurities in pharmaceuticals.
Auburn, AL, September 24, 2024 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science, announced that its N-Sorb nitrosamine mitigation solution has been accepted into the U.S. Food & Drug Administration’s (FDA) Emerging Technology Program (ETP), which helps promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.